Brain stimulation without surgery for working memory in older adults
Tests scalp brain stimulation on working memory in older adults.
Key facts
- Who runs it
- Masaryk University
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory
- Status
- Recruiting
- People taking part
- 70 people, planned
- Started
- 1 Mar 2026
- Planned end
- Jul 2026
- Type of study
- Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (20 Hz)
- Control striatal stimulation
- Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (60 Hz)
- Record updated
- 1 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy older adults and older adults with mild memory and thinking problems linked to Lewy body disease or Parkinson's disease. It tests non-invasive electrical brain stimulation together with MRI scans.
- Age
- 60 Years to 80 Years
- Sex
- All sexes can join.
- Disease stage
- Healthy people need normal results on a memory and thinking screening test. Patients need possible or probable mild cognitive impairment (MCI) with Lewy bodies, or MCI with Parkinson's disease (PD), shown by a full memory and thinking examination. For MCI with Lewy bodies, people need at least two of four core features: parkinsonism, seeing things that are not there, changes in attention or thinking, and acting out dreams during REM sleep. Or they need at least 1 core feature and 1 supporting biomarker.
- Biomarker or test result
- For probable MCI with Lewy bodies, at least 1 indicative biomarker can replace one of the core features.
Main reasons for not taking part
- Psychiatric disorders, including major depression
- Major damage to blood vessels in the brain
- Other brain diseases that can cause a decline in memory and thinking
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- normal cognitive performance as assessed by a cognitive screening for healthy subjects
- possible or probable MCI-LB or with PD-MCI, collectively called MCI-LBD, described as: presence of PD , and level II criteria for MCI (i.e. based on comprehensive neuropsychological examination), or the level II criteria for MCI , and at least two of four core DLB features including parkinsonism, visual hallucinations, attention/cognitive function fluctuation, and REM sleep behavioral disorder, or at least 1 core clinical feature and 1 indicative biomarker (probable MCI-LB)
Who cannot take part
- Psychiatric disorders including major depression, major vascular lesions, or other brain pathologies that might present with cognitive decline
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 60 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
A study investigating the effects of non-invasive electrical stimulation of deep brain structures on working memory, attention, and executive functions involved in everyday activities. Currently, there is no effective treatment for impairments in these functions. The study will evaluate the effects of non-invasive electrical stimulation in both healthy older adults and individuals with mild impairment of these functions.
Read full original descriptionShow less
The study combines magnetic resonance imaging (MRI) with non-invasive brain stimulation targeting deep brain structures. Its aim is to improve understanding of the neural mechanisms underlying these cognitive functions and their impairments, as well as to explore the mechanisms of non-invasive brain stimulation for potential future therapeutic applications.
The 3 groups in the trial
- 20 Hz striatal stimulationTreatment being tested
Striatum will be targeted by using two pairs of high-frequency tES with a low-frequency offset (20 Hz), creating an interference hotspot targeting the deep brain structure (deep-tES).
Treatment: Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (20 Hz)
- 60 Hz striatal stimulationTreatment being tested
Striatum will be targeted by using two pairs of high-frequency tES with a low-frequency offset (60 Hz), creating an interference hotspot targeting the deep brain structure (deep-tES).
Treatment: Non-invasive deep brain stimulation of striatum via transcranial temporal interference stimulation (60 Hz)
- Sham striatal stimulationSham treatment, for comparison
Striatum will be targeted by using two pairs of high-frequency tES with no low-frequency offset. The stimulation will be applied only shortly and turned off after ramp-up and ramp-down period.
Treatment: Control striatal stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Non-invasive Stimulation of Deep Brain Structures to Modulate Working Memory
- Plain-language title
- Brain stimulation without surgery for working memory in older adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07560904, who can take part
- Record updated
- 1 May 2026